YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction

Published:2018-12 Issue:12 Volume:1864 Page:3786-3798
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Dai Chun-Hua,Shu Yang,Chen Ping,Wu Jian-Nong,Zhu Li-Haun,Yuan Rong-Xia,Long Wei-Guo,Zhu Yu-Min,Li Jian

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Jiangsu Province

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference51 articles.

1. Treatment of stage IV non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-base Clinical Practice Guidelines;Socinski;Chest,2013

2. Recent clinical advances in lung cancer management;Johnso;J. Clin. Oncol.,2014

3. Rational biologically based treatment of EGFR-mutant non-small-cell lung cancer;Pao;Nat. Rev. Cancer,2010

4. Treatment of non-small-cell lung cancer with erlotinib or gefitinib;Cataldo;N. Engl. J. Med.,2011

5. Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma;Cadranel;Crit. Rev. Oncol. Hematol.,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Novel Prognostic Panel for Colorectal Cancer Based on Cancer Functional Status, and Validation of STC2 as a Promising Biomarker;Frontiers in Bioscience-Landmark;2024-07-02

2. Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFR^WT and EGFR^T790M: integrating biological, molecular docking, and ADMET analysis;RSC Advances;2024

3. Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC;International Journal of Molecular Sciences;2023-12-22

4. Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy;Immunological Reviews;2023-09-08

5. Synergistic augmentation of osimertinib‐induced autophagic death by proguanil or rapamycin in bladder cancer;MedComm;2023-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3